- Health
Brain Health round table event - EP BrainHealth
This round table event looks at how regional brain health ideas can reach a larger audience and seeks to encourage dialogue between innovation and implementation.
Read moreEvents
This was 1 year ago
Berlin, Germany
The first EP PerMed Conference on 11 and 12 February will provide an international forum for up to 400 participants to present and discuss research and methodologies in various fields supporting the development of personalised medicine approaches. The event is an opportunity for experts in the field to create new connections and research networks.
Back-to-back with the conference, EP PerMed is organising a training workshop on “Training on Scientific Integrity” on 12 and 13 February. The number of participants to the training workshop is limited. Register on the event's webpage.
More information on the conference and registration on the EP PerMed website.
Background: The European Partnership for Personalised Medicine (EP PerMed) brings together European as well as international, national and regional ministries and funding organisations, agencies and authorities, joining forces on several levels and sectors. To realise the full potential of personalised medicine (PM), EP PerMed supports the entire PM value continuum by a wide range of definite actions, including joint research funding and supporting activities among others.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
This round table event looks at how regional brain health ideas can reach a larger audience and seeks to encourage dialogue between innovation and implementation.
Read moreAs climate impacts intensify across Europe, this Forum will spotlight practical and replicable adaptation solutions that are making a difference on the ground. Participants will explore innovative tools being developed through Mission Projects to boost climate resilience, collaborate to co-design solutions tailored to their communities, and...
Read moreThe Disaster Resilience Days 2026 is a three-day European forum bringing together researchers, policymakers, civil protection authorities, first responders, critical infrastructure operators, security and defence actors, industry, and innovators to strengthen disaster resilience and crisis preparedness through research, innovation and...
Read moreThe European Institute of Innovation and Technology (EIT) Health Summit 2026 will take place in Madrid this year, in collaboration with the Madrid Regional Health Ministry. As EIT Health marks its tenth anniversary, this year’s Summit aims to provide an opportunity to reflect on what the community has achieved together over the past decade,...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.